Keyphrases
5-Aminoimidazoles
60%
Acetyl-CoA Carboxylase
40%
AMP-activated Protein Kinase Pathway
20%
AMPK Activator
100%
Antitumor Effect
20%
BRAF Gene
20%
BRAF mutant
20%
Carboxamide
60%
Cell Cycle Arrest
20%
Cell Cycle Inhibitors
20%
Cell Death
20%
Cell Growth
20%
Cell Proliferation
20%
Combination Therapy
20%
Constitutively Active
20%
Dose Effect
20%
Downstream Targets
20%
Drug Treatment
20%
Energy Stress
20%
Enzymatic Activity
40%
ERK Pathway
40%
Human Melanoma
100%
In Vitro Proliferation
20%
In Vivo Growth
20%
Liver Kinase B1 (LKB1)
20%
Melanoma
20%
Melanoma Cells
100%
Mitogen-activated Protein Kinase
100%
Necrosis
20%
NRAS mutation
20%
NRAS-mutant Melanoma
20%
P21 Expression
20%
Pharmacological Activators
20%
Phenformin
40%
Phosphorylation
60%
Raf-MEK-ERK
40%
Ribonucleosides
60%
Senescence-associated
20%
Sigma Phase
20%
Stress Conditions
20%
Xenograft Mice
20%
β-Galactosidase (β-Gal)
20%
Medicine and Dentistry
5 Amino 4 Imidazolecarboxamide
37%
Acetyl-CoA
25%
AMP-Activated Protein Kinase
100%
BRAF (Gene)
12%
Carboxylase
25%
Cell Cycle
25%
Cell Cycle Arrest
12%
Cell Cycle Checkpoint
12%
Cell Death
12%
Cell Growth
12%
Cell Proliferation
12%
Combination Therapy
12%
Drug Therapy
12%
Enzyme Activity
25%
Galactosidase
12%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
12%
In Vitro
12%
Melanoma
100%
Melanoma Cell
50%
Melanoma Cell Line
12%
Mitogen-Activated Protein Kinase
100%
Necrosis
12%
P21
25%
Phenformin
25%
Phosphotransferase
25%
Ribonucleoside
37%
S Phase
12%
Xenograft
12%
Pharmacology, Toxicology and Pharmaceutical Science
5 Amino 4 Imidazolecarboxamide
37%
Acetyl-CoA
25%
Carboxylase
25%
Combination Therapy
12%
Galactosidase
12%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
12%
Melanoma
100%
Necrosis
12%
Nude Mouse
12%
Pharmacotherapy
12%
Phenformin
25%
Phosphotransferase
25%
Ribonucleoside
37%